HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ling-Bo Liu Selected Research

Acute Myelomonocytic Leukemia

10/2006[Depressing the immune escape of acute myelomonocytic leukemia via an anti-Fas ribozyme].
6/2006[Expression of immune response molecules and function of fas ligand on surface of AML WEHI-3 cells].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ling-Bo Liu Research Topics

Disease

2Leukemia
10/2006 - 12/2003
2Acute Myelomonocytic Leukemia
10/2006 - 06/2006
2Neoplasms (Cancer)
10/2005 - 12/2003
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2015
1Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
04/2008
1Graft vs Host Disease (Graft-Versus-Host Disease)
10/2003
1Lymphoma (Lymphomas)
08/2002

Drug/Important Bio-Agent (IBA)

3Fas Ligand Protein (Fas Ligand)IBA
10/2006 - 12/2003
2Complementary DNA (cDNA)IBA
10/2005 - 10/2003
1ResveratrolIBA
08/2015
1Phosphotransferases (Kinase)IBA
08/2015
1LipofectamineIBA
04/2008
1Small Interfering RNA (siRNA)IBA
04/2008
1Catalytic RNA (Ribozymes)IBA
10/2006
1hammerhead ribozymeIBA
10/2006
1Messenger RNA (mRNA)IBA
10/2005
1DNA (Deoxyribonucleic Acid)IBA
10/2005
1Liposomes (Liposome)IBA
10/2003
1Annexin A5IBA
08/2002
1Proteins (Proteins, Gene)FDA Link
08/2002

Therapy/Procedure

1Immunotherapy
08/2002